Steve Braunstein
Papers
3
Total Citations
16
H-Index
3
About
Steve Braunstein is a leading researcher in radiation oncology, with a primary focus on stereotactic body radiotherapy (SBRT) for lung and spine cancers. His work centers on optimizing treatment precision and minimizing toxicity, particularly through advanced respiratory motion management and dose calculation techniques. Braunstein’s major contributions include demonstrating that real-time tumor tracking (RTT) significantly reduces radiation pneumonitis risk compared to the internal target volume (ITV) method in lung SBRT, a finding with direct clinical implications for patient safety. He has also rigorously evaluated dose calculation algorithms, showing the superiority of Monte Carlo over Ray Tracing methods for tumors in low-density lung tissue, thereby improving treatment accuracy. In spine SBRT, Braunstein derived a mathematical formula correlating small-volume spinal cord doses to critical safety parameters, providing a practical tool for clinicians. His most cited work (9 citations) on respiratory motion management underscores his impact on refining SBRT delivery. Through these studies, Braunstein has advanced the field’s understanding of how to balance tumor control with normal tissue sparing, making him a key contributor to safer, more effective radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3